Daiken Biomedical Co

Daiken Biomedical Co FCF per Share

The Free Cash Flow per Share of Daiken Biomedical Co (7780.TWO) as of Oct 16, 2026 is 0.84 TWD. In the previous year, Free Cash Flow per Share was 1.75 TWD — a change of -52.00% (lower).

FCF per Share

0.84TWD

YoY

-52.00%

Last updated:

Free Cash Flow per Share of Daiken Biomedical Co is 2024 0.84 TWD. Free Cash Flow per Share of Daiken Biomedical Co was 2023 1.75 TWD. It decreases by -52.00% lower compared to the previous year.

The Daiken Biomedical Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2022
0.69 TWD
Jan 1, 2023
1.75 TWD
Jan 1, 2024
0.84 TWD
The Daiken Biomedical Co FCF per Share history
YEARFCF per ShareYoY
0.84TWD-52.00%
1.75TWD+153.34%
0.69TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Daiken Biomedical Co Stock analysis

What does Daiken Biomedical Co do? Daiken Biomedical Co Ltd is a company based in Taipei City, Taiwan, with its headquarters located in Taipei City. The company made its initial public offering (IPO) on October 28, 2024, and is listed under the ticker symbol 7780.TWO with ISIN TW0007780009. Daiken Biomedical operates in the health food sector, focusing on the research, development, and sales of health food products. The company's product portfolio includes fish oil, lutein, maca, bitter melon peptide cinnamon capsules, women's probiotics, good sleep sesamin, and high dietary fiber powder packets. Sales are conducted through multiple channels, including the company's official website, online platforms such as Momo, Shopee, and PChome, as well as physical retail locations like Watsons, FamilyMart, and Cosmetics. The firm primarily serves the Taiwan market, with operations centered within Taiwan. The company's website is https://www.daikenshop.com/. Daiken Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Daiken Biomedical Co stock

Free Cash Flow per Share of Daiken Biomedical Co is 0.84 TWD in 2024.

Free Cash Flow per Share of Daiken Biomedical Co changed from 1.75 TWD to 0.84 TWD, representing a -52.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Daiken Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Daiken Biomedical Co

All Key Metrics — Daiken Biomedical Co